Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001842952-24-000085
Filing Date
2024-11-06
Accepted
2024-11-06 16:02:40
Documents
55
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cntx-20240930.htm   iXBRL 10-Q 648997
2 EX-31.1 cntx2024-093010xqexhibit311.htm EX-31.1 10765
3 EX-31.2 cntx2024093010-qexhibit312.htm EX-31.2 10767
4 EX-32.1 cntx2024093010-qexhibit321.htm EX-32.1 6579
  Complete submission text file 0001842952-24-000085.txt   3678752

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cntx-20240930.xsd EX-101.SCH 25666
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cntx-20240930_cal.xml EX-101.CAL 28830
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cntx-20240930_def.xml EX-101.DEF 90252
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cntx-20240930_lab.xml EX-101.LAB 420103
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cntx-20240930_pre.xml EX-101.PRE 278144
57 EXTRACTED XBRL INSTANCE DOCUMENT cntx-20240930_htm.xml XML 350522
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

EIN.: 863738787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40654 | Film No.: 241430808
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)